ArticleCancer immunology, immunotherapy : CII2007

T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005.

Elisabeth Ersvaer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.